Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib

Saved in:
Bibliographic Details
Published inAmerican journal of hematology Vol. 97; no. 12; pp. E433 - E435
Main Authors Tefferi, Ayalew, Pardanani, Animesh, Begna, Kebede H., Al‐Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.12.2022
Wiley Subscription Services, Inc
Subjects
Humans
Inhibitor drugs
Myelofibrosis
Nitriles
Primary Myelofibrosis - drug therapy
Pyrimidines - therapeutic use
Retrospective Studies
Online AccessGet full text
ISSN0361-8609
1096-8652
1096-8652
DOI10.1002/ajh.26714

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Correspondence-1
ISSN:0361-8609
1096-8652
1096-8652
DOI:10.1002/ajh.26714